Ownership

Greg Zante - Insider Trading & Ownership

Entity: Individual
Location: C/O Sangamo Biosciences, Inc Ste A 100, Point Richmond Tech, 501 Canal Blvd,, Richmond, CA
Summary: The estimated net worth of Greg Zante is at least $20.5M dollars as of January 6, 2025. Greg Zante is the Chief Financial Officer of Viking Therapeutics, Inc. and owns shares of Viking Therapeutics, Inc. (VKTX) stock worth about $20.5M.
All Insider Reports: All Insider Reports

Ownership of Greg Zante

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
VKTX	Viking Therapeutics, Inc.	Chief Financial Officer	$20.5M	-$18.1M	-47%	Jan 3, 2025

Insider Transactions Reported by Greg Zante:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.